Drug intelligence / Profile preview

yi-fei san-jie pill

Development stage
Phase 4
Lead developer
First Affiliated Hospital of Guangzhou University of Chinese Medicine
Modality
Small Molecules
Administration
Oral
01

Overview

Yi-Fei San-Jie Pill (YFSJ) is a traditional Chinese medicine formula widely used as an adjunctive therapy for non-small cell lung cancer (NSCLC), particularly in China. It is composed of multiple herbal ingredients and has been validated in clinical studies for its efficacy in NSCLC treatment[1][4]. YFSJ exerts anti-tumor effects through several mechanisms, including inhibition of epithelial-mesenchymal transition (EMT), suppression of tumor angiogenesis, promotion of apoptosis, and inhibition of cell proliferation[1][2][4]. Mechanistically, YFSJ targets key signaling pathways such as the EGFR/p-p38 MAPK/GSK3β axis and the PI3K/AKT pathway to suppress EMT and enhance sensitivity to targeted therapies like gefitinib[1][4]. Additionally, it alleviates chemotherapy-related fatigue by reducing oxidative stress and skeletal muscle injury via modulation of the AMPK/mTOR pathway[3][5]. The formula contains herbs such as Mao Zhua Cao (Herba Hedyotidis Diffusae), Shan Ci Gu (Bulbus Cremastrae seu Pleiones), and Ling Zhi (Ganoderma lucidum), which contribute to its anti-cancer properties by inhibiting tumor angiogenesis and supporting immune function[2].

Brand names
yi-fei san-jie pill
Other names
yifei sanjie pillyifei sanjie formulayfsjyfsjf
02

Targets

STAT3 (Signal Transducer and Activator of Transcription 3)TNFA (Tumor necrosis factor alpha (soluble))AKT (RAC-alpha serine/threonine-protein kinase)EGFR (Epidermal growth factor receptor)GSK3 (Glycogen synthase kinase 3 beta)PIK3CA (Phosphoinositide 3-kinase alpha)PIK3R1 (Phosphatidylinositol 4-phosphate 3-kinase regulatory subunit alpha)MAPK14 (p38 mitogen-activated protein kinase alpha)

Beyond the preview

Go deeper on yi-fei san-jie pill.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on yi-fei san-jie pill.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call